AI assistant
UroGen Pharma Ltd. — Director's Dealing 2021
Jul 12, 2021
32312_dirs_2021-07-12_30e87ea9-7579-46f8-8cf7-9191c4269a4e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2020-02-03
Reporting Person: Barrett Elizabeth A. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-03 | Ordinary Shares | M | 8807 | — | Acquired | 131043 | Direct |
| 2020-03-03 | Ordinary Shares | M | 8807 | — | Acquired | 139850 | Direct |
| 2020-04-03 | Ordinary Shares | M | 8807 | — | Acquired | 148657 | Direct |
| 2020-05-03 | Ordinary Shares | M | 8808 | — | Acquired | 157465 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-03 | Restricted Stock Units | $ | M | 8807 | Disposed | Ordinary Shares (8807) | Direct | |
| 2020-03-03 | Restricted Stock Units | $ | M | 8807 | Disposed | Ordinary Shares (8807) | Direct | |
| 2020-04-03 | Restricted Stock Units | $ | M | 8807 | Disposed | Ordinary Shares (8807) | Direct | |
| 2020-05-03 | Restricted Stock Units | $ | M | 8808 | Disposed | Ordinary Shares (8808) | Direct |
Footnotes
F1: On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020.
F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years.